← Back to guidelines
Cardiology1 paper

Neuritis of saphenous nerve

Last edited: 4/23/2026

Overview

Saphenous nerve neuritis, often localized at the adductor canal, presents with predominant anterior knee pain and can persist for extended periods, typically over 3 years 1.

Diagnosis

  • Clinical criteria include anterior knee pain localized to the saphenous nerve distribution.
  • Diagnostic confirmation often involves saphenous nerve blocks at the adductor canal.
  • No specific grading system mentioned; diagnosis relies on clinical presentation and response to nerve blocks 1.
  • Management

  • First-line Treatment: Saphenous nerve blocks at the adductor canal, with an average of 1.9 blocks per patient showing significant pain reduction 1.
  • Adjunctive Treatments: Not explicitly detailed in the provided abstract; conservative management approaches may include physical therapy and NSAIDs, though specific dosing is not mentioned 1.
  • Special Populations

  • No specific data on pregnancy, pediatrics, elderly, or comorbidities related to saphenous nerve neuritis in the provided abstracts 1.
  • Key Recommendations

  • Perform saphenous nerve blocks at the adductor canal for diagnosis and treatment of saphenous nerve entrapment, with significant pain reduction observed 1 (Evidence: Moderate).
  • Consider prolonged symptom duration as a factor influencing treatment outcomes, as longer duration correlates with less favorable final pain levels 1 (Evidence: Moderate).
  • Monitor response to nerve blocks as a primary indicator of treatment efficacy, with 80% improvement noted in the study population 1 (Evidence: Moderate).
  • References

    1 Romanoff ME, Cory PC, Kalenak A, Keyser GC, Marshall WK. Saphenous nerve entrapment at the adductor canal. The American journal of sports medicine 1989. link

    Original source

    1. [1]
      Saphenous nerve entrapment at the adductor canal.Romanoff ME, Cory PC, Kalenak A, Keyser GC, Marshall WK The American journal of sports medicine (1989)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG